{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:03:39Z","timestamp":1793714619886,"version":"4.6.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["BRC1280\/PPI\/CS\/104990"],"award-info":[{"award-number":["BRC1280\/PPI\/CS\/104990"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["MR\/X030725\/1"],"award-info":[{"award-number":["MR\/X030725\/1"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["MRF-RGM-ED-24-107"],"award-info":[{"award-number":["MRF-RGM-ED-24-107"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["225993\/Z\/22\/Z"],"award-info":[{"award-number":["225993\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eclinm.2026.104007","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:36:06Z","timestamp":1784180166000},"page":"104007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on binge eating in patients with obesity: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"98","author":[{"given":"Isobel","family":"Emptage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2121-5022","authenticated-orcid":false,"given":"Stella","family":"Kozm\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antemeka","family":"Cobham-Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Sugden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Llewellyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Makaronidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Bulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eclinm.2026.104007_bib1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S2215-0366(21)00040-7","article-title":"The hidden burden of eating disorders: an extension of estimates from the Global Burden of Disease Study 2019","volume":"8","author":"Santomauro","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-022-00344-y","article-title":"Binge eating disorder","volume":"8","author":"Giel","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/wps.21182","article-title":"Outcomes in people with eating disorders: a transdiagnostic and disorder-specific systematic review, meta-analysis and multivariable meta-regression analysis","volume":"23","author":"Solmi","year":"2024","journal-title":"World Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104007_bib4","first-page":"1","article-title":"Mortality and hospital admissions in people with eating disorders: longitudinal cohort study in secondary care-linked English primary care records","author":"Jeffery","year":"2025","journal-title":"Br J Psychiatr"},{"issue":"52","key":"10.1016\/j.eclinm.2026.104007_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002098","article-title":"Obese patients with a binge eating disorder have an unfavorable metabolic and inflammatory profile","volume":"94","author":"Succurro","year":"2015","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104007_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40211-020-00346-w","article-title":"A review of binge eating disorder and obesity","volume":"35","author":"Ag\u00fcera","year":"2021","journal-title":"Neuropsychiatrie"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104007_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2012.11.020","article-title":"The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys","volume":"73","author":"Kessler","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104007_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/jama.2015.18118","article-title":"Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis","volume":"315","author":"Dawes","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.104007_bib9","article-title":"Four decades of psychological treatment for bulimia nervosa and binge-eating disorder: a meta-regression of changes in abstinence rates over time","volume":"4","author":"Messer","year":"2025","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.eclinm.2026.104007_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/TCRM.S25574","article-title":"Pharmacological management of binge eating disorder: current and emerging treatment options","volume":"8","author":"McElroy","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.eclinm.2026.104007_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/eat.24109","article-title":"Use of glucagon-like peptide-1 receptor agonists in eating disorder populations","volume":"57","author":"Bartel","year":"2024","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.eclinm.2026.104007_bib13","article-title":"GLP-1 receptor agonists: a novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review","volume":"35","author":"Aoun","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104007_bib14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4093\/dmj.2023.0277","article-title":"Glucagon-like peptide-1: new regulator in lipid metabolism","volume":"48","author":"Bu","year":"2024","journal-title":"Diabetes Metab J"},{"issue":"22","key":"10.1016\/j.eclinm.2026.104007_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262210974","article-title":"Neurobiological mechanisms and therapeutic potential of glucagon-like Peptide-1 receptor agonists in binge eating disorder: a narrative review","volume":"26","author":"Tongta","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104007_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cph4.70129","article-title":"GLP-1 at the metabolic\u2013cognitive interface: reward, affect, and memory","volume":"16","author":"Gao","year":"2026","journal-title":"Compr Physiol"},{"key":"10.1016\/j.eclinm.2026.104007_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.103049","article-title":"The impact of weight loss interventions on disordered eating symptoms in people with overweight and obesity: a systematic review & meta-analysis","volume":"80","author":"Tsompanaki","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib18","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0405","article-title":"The emerging role of glucagon-like peptide 1 in binge eating","volume":"262","author":"Balantekin","year":"2024","journal-title":"J Endocrinol"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104007_bib19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamapsychiatry.2025.0679","article-title":"Glucagon-like peptide 1 receptor agonists and mental health","volume":"82","author":"Pierret","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104007_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s44220-025-00390-x","article-title":"An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders","volume":"3","author":"De Giorgi","year":"2025","journal-title":"Nature Mental Health"},{"key":"10.1016\/j.eclinm.2026.104007_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mehy.2017.12.029","article-title":"Would glucagon-like peptide-1 receptor agonists have efficacy in binge eating disorder and bulimia nervosa? A review of the current literature","volume":"111","author":"McElroy","year":"2018","journal-title":"Med Hypotheses"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104007_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70661","article-title":"Efficacy and safety of glucagon-like Peptide-1 agonists for psychiatric symptoms: a systematic review","volume":"15","author":"Meshkat","year":"2025","journal-title":"Brain Behav"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104007_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s40501-024-00331-y","article-title":"The impact of GLP-1 receptor agonists (GLP-1 RAs) on mental health: a systematic review","volume":"11","author":"Tempia Valenta","year":"2024","journal-title":"Curr Treat Options Psychiatry"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s40519-025-01720-9","article-title":"The impact of glucagon-like peptide-1 (GLP-1) agonists in the treatment of eating disorders: a systematic review and meta-analysis","volume":"30","author":"Radkhah","year":"2025","journal-title":"Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity"},{"key":"10.1016\/j.eclinm.2026.104007_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/eat.24575","article-title":"Effects of GLP-1 receptor agonist therapy on eating disorder risk and psychological distress in adults with class 3 obesity","volume":"59","author":"Maynard","year":"2026","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.eclinm.2026.104007_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2026.108502","article-title":"Cognitive restraint versus restriction: an investigation of daily eating patterns among women with eating disorders characterized by restriction","volume":"222","author":"Trolio","year":"2026","journal-title":"Appetite"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104007_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14093122","article-title":"Glucagon-like Peptide-1 receptor agonists in the context of eating disorders: a promising therapeutic option or a double-edged sword?","volume":"14","author":"Ka\u0142as","year":"2025","journal-title":"J Clin Med"},{"issue":"10445","key":"10.1016\/j.eclinm.2026.104007_bib28","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/S0140-6736(24)00874-2","article-title":"The evolving profile of eating disorders and their treatment in a changing and globalised world","volume":"403","author":"Himmerich","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104007_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/erv.1100","article-title":"Body image disturbance in binge eating disorder: a review","volume":"19","author":"Ahrberg","year":"2011","journal-title":"Eur Eat Disord Rev"},{"key":"10.1016\/j.eclinm.2026.104007_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bodyim.2025.101890","article-title":"Body image and interest in GLP-1 weight loss medications","volume":"53","author":"Markey","year":"2025","journal-title":"Body Image"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104007_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2026.104007_bib34","series-title":"EndNote","year":"2013"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104007_bib36","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1111\/dom.15802","article-title":"Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: a randomized controlled trial","volume":"26","author":"Gabe","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104007_bib37","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1111\/dom.16662","article-title":"Association between patient-reported eating behaviours and weight change: secondary analyses of a randomized, double-blind trial comparing retatrutide and placebo in people with obesity or overweight","volume":"27","author":"Kanu","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eclinm.2026.104007_bib38","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.1111\/dom.70097","article-title":"Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: results of a phase 2 study","volume":"27","author":"Kanu","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eclinm.2026.104007_bib39","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"28","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12874-018-0483-0","article-title":"Dealing with missing standard deviation and mean values in meta-analysis of continuous outcomes: a systematic review","volume":"18","author":"Weir","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.eclinm.2026.104007_bib41","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 6: choosing effect measures and computing estimates of effect [last updated August 2023]","author":"Higgins","year":"2024"},{"key":"10.1016\/j.eclinm.2026.104007_bib42","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 10: analysing data and undertaking meta-analyses [last updated November 2024]","author":"Higgins","year":"2024"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104007_bib43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis","volume":"53","author":"Sterne","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104007_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ejendo\/lvae024","article-title":"Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial","volume":"190","author":"Gatta-Cherifi","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104007_bib45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00125-023-06053-9","article-title":"Dose\u2013response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon\/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial","volume":"67","author":"Bl\u00fcher","year":"2024","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104007_bib46","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104007_bib47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/osp4.619","article-title":"A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder","volume":"9","author":"Allison","year":"2023","journal-title":"Obes Sci Pract"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104007_bib48","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/oby.22653","article-title":"Effects of liraglutide and behavioral weight loss on food cravings, eating behaviors, and eating disorder psychopathology","volume":"27","author":"Chao","year":"2019","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104007_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.dsx.2020.03.009","article-title":"Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: a pilot study","volume":"14","author":"Da Porto","year":"2020","journal-title":"Diabetes Metabol Syndr: Clin Res Rev"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104007_bib50","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.9676","article-title":"Efficacy of liraglutide for weight loss among patients with type 2 diabetes","volume":"314","author":"Davies","year":"2015","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.eclinm.2026.104007_bib51","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/dom.14050","article-title":"Effect of liraglutide on food consumption, appetite sensations and eating behaviours in overweight people with type 1 diabetes","volume":"22","author":"Dub\u00e9","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104007_bib52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104007_bib53","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.14255","article-title":"Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes","volume":"23","author":"Gibbons","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104007_bib54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/ajcn\/nqaa328","article-title":"Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial","volume":"113","author":"Gudbergsen","year":"2021","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib55","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1038\/s41467-022-32307-y","article-title":"Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment","volume":"13","author":"Jensen","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s13063-021-05442-y","article-title":"Does intervention with GLP-1 receptor agonist semaglutide modulate perception of sweet taste in women with obesity: study protocol of a randomized, single-blinded, placebo-controlled clinical trial","volume":"22","author":"Jensterle","year":"2021","journal-title":"Trials"},{"issue":"10317","key":"10.1016\/j.eclinm.2026.104007_bib57","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","article-title":"Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial","volume":"398","author":"Lau","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104007_bib58","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1038\/s41591-025-03774-9","article-title":"Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial","volume":"31","author":"Martin","year":"2025","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104007_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/JCP.0000000000001803","article-title":"Liraglutide in obese or overweight individuals with stable bipolar disorder","volume":"44","author":"McElroy","year":"2024","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104007_bib61","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.orcp.2015.03.005","article-title":"Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide \u2013 a pilot study","volume":"9","author":"Robert","year":"2015","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.eclinm.2026.104007_bib62","author":"Wadden"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104007_bib63","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/oby.23673","article-title":"Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight\/obesity: STEP-5","volume":"31","author":"Wharton","year":"2023","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2337\/dc25-2379","article-title":"Tirzepatide in adults with type 1 diabetes: a phase 2 randomized placebo-controlled clinical trial","volume":"49","author":"Snaith","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eclinm.2026.104007_bib65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2025.04.046","article-title":"A double-blind, placebo-controlled trial of exenatide for the treatment of olanzapine-related weight gain in obese and overweight adults","volume":"382","author":"Patino","year":"2025","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-3999(85)90010-8","article-title":"The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger","volume":"29","author":"Stunkard","year":"1985","journal-title":"J Psychosom Res"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104007_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0306-4603(82)90024-7","article-title":"The assessment of binge eating severity among obese persons","volume":"7","author":"Gormally","year":"1982","journal-title":"Addict Behav"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104007_bib68","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ejcn.2015.57","article-title":"Preliminary validation and principal components analysis of the Control of Eating Questionnaire (CoEQ) for the experience of food craving","volume":"69","author":"Dalton","year":"2015","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104007_bib69","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/eat.24342","article-title":"Unpacking the controversies of weight loss and dietary restraint with binge-eating disorder: commentary on grilo and pittman","volume":"58","author":"Balantekin","year":"2025","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.eclinm.2026.104007_bib70","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/d41573-025-00155-2","article-title":"The evolution of the obesity drug market","volume":"24","author":"Recasens-Alvarez","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.eclinm.2026.104007_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-085304","article-title":"Weight regain after cessation of medication for weight management: systematic review and meta-analysis","volume":"392","author":"West","year":"2026","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104007_bib72","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1038\/s41591-025-04035-5","article-title":"Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide","volume":"31","author":"Choi","year":"2025","journal-title":"Nat Med"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:33:10Z","timestamp":1787862790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026002567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":69,"alternative-id":["S2589537026002567"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104007","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on binge eating in patients with obesity: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104007"}}